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Background: Dietary factors such as folate, vitamin B12, protein, and methionine are important for the excretion of
arsenic via one-carbon metabolism in undernourished populations exposed to high levels of arsenic via drinking
water. However, the effects of dietary factors on toenail arsenic concentrations in well-nourished populations
exposed to relatively low levels of water arsenic are unknown.
Methods: As part of a population-based case–control study of skin and bladder cancer from the USA, we evaluated
relationships between consumption of dietary factors and arsenic concentrations in toenail clippings. Consumption
of each dietary factor was determined from a validated food frequency questionnaire. We used general linear
models to examine the associations between toenail arsenic and each dietary factor, taking into account potentially
confounding effects.
Results: As expected, we found an inverse association between ln-transformed toenail arsenic and consumption of
vitamin B12 (excluding supplements) and animal protein. Unexpectedly, there were also inverse associations with
numerous dietary lipids (e.g., total fat, total animal fat, total vegetable fat, total monounsaturated fat, total
polyunsaturated fat, and total saturated fat). Finally, increased toenail arsenic concentrations were associated with
increased consumption of long chain n-3 fatty acids.
Conclusion: In a relatively well-nourished population exposed to relatively low levels of arsenic via water,
consumption of certain dietary lipids may decrease toenail arsenic concentration, while long chain n-3 fatty acids
may increase toenail arsenic concentration, possibly due to their association with arsenolipids in fish tissue.
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Exposure to arsenic has been established as a significant
human health threat. Chronic exposure to high concen-
trations of arsenic can cause skin lesions, cancer, devel-
opmental toxicity, neurotoxicity, cardiovascular diseases,
and other health effects [1,2]. Long-term exposure to
lower concentrations of arsenic is also of concern [3-5].
Millions of people worldwide are at risk due to con-
sumption of water contaminated with inorganic arsenic
[6,7], and we are all exposed to arsenic via food [1]. For* Correspondence: kathryn.cottingham@dartmouth.edu
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reproduction in any medium, provided the orexample, staple foods such as rice contain appreciable
arsenic concentrations, especially of the more toxic, in-
organic forms [1,8-13]. Seafood – including fish – is also
high in arsenic, but in the less-toxic, organic forms [14].
Recent studies suggest that in the general population,
which consumes relatively small concentrations of ar-
senic in drinking water, diet plays a dominant role in
overall exposure [1,8-13].
However, foods also contain factors that are important
for one-carbon metabolism, the process by which inor-
ganic arsenic (iAs) is methylated [15,16] and removed
from the body. The process of methylation has two
steps: first, monomethylarsonic acid (MMA) is formed,
and then dimethylarsinic acid (DMA). All three formsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[17-20], but DMA is the most prevalent form of arsenic
in urine [21]. DMA is generally believed to be less toxic
than iAs, while the trivalent form of the intermediate
product MMA may be the most toxic [20]. In popula-
tions with nutritional deficiencies and high exposure to
inorganic arsenic via drinking water, dietary factors im-
portant to complete one-carbon metabolism – including
folic acid [18,22,23], vitamin B12 [24], protein [24-26],
and methionine [24,25] – appear to facilitate the excre-
tion of arsenic from the body.
Less is known about the impact of dietary factors on
the concentrations of arsenic in biologic tissues, such as
toenails, over periods of months to years. Arsenic that
has not been methylated (i.e., iAs) has a high affinity for
keratin, which is found in high concentrations in nails
and hair [27]. As a result, iAs can accumulate in hair
and nails [27,28], both of which have been used as bio-
markers of chronic exposure [29]. For example, toenail
arsenic concentrations have been used as a biomarker of
exposure both via water and foods [30-32].
We investigated the associations between toenail ar-
senic concentration and dietary factors in a population-
based study in New Hampshire, USA. Based on previous
studies with short-term biomarkers (blood, urine), we
hypothesized that the dietary factors important for one-
carbon metabolism (including folate, vitamin B12, me-




We analyzed existing data from population-based case–
control studies of bladder and skin cancer conducted
among 25 to 74 year old residents of New Hampshire
who utilize private groundwater wells as their household
water source [33]. Groundwater arsenic concentrations
for this population vary spatially, from <0.0003 to 180
μg/L across the state [34,35], creating a natural gradient
of exposure to inorganic arsenic via drinking water. The
Committee for the Protection of Human Subjects
(CPHS) of Dartmouth College approved study materials
and protocols (current CPHS #10107 & #11697) and
participants provided informed consent according to the
approved protocol.
Data collection
Details of the study design are provided elsewhere
[33,36-39]. Briefly, participants were interviewed, usually
in their home, to obtain information on sociodemo-
graphic factors (e.g., smoking history, drinking water
source). To minimize potential reporting biases, inter-
viewers were masked to the case–control status of parti-
cipants and neither interviewers nor participants wereaware of the original study hypotheses [39]. Eighty-five
percent of cases and 70% of controls were interviewed
during the bladder cancer study [40], and 82% of cases
and 73% of controls were interviewed in the skin cancer
study [41].
Beginning November 1999 for bladder cancer cases,
and August 2000 for skin cancer cases and controls,
we asked participants to complete a written, validated,
semi-quantitative food frequency questionnaire (FFQ)
covering the preceding 12 month period [42,43]. More
than 75% responded to this request. The FFQ asked
about the consumption of 121 different items from
seven broad categories (dairy, fruits, vegetables, eggs and
meat, breads, beverages, and baked goods), as well as
dietary supplements (e.g., vitamins), during the past year.
Frequency options ranged from never to six or more
times a day. Using this instrument, nutrient composition
of each food was calculated according to the published
methods of Willett and colleagues [44]. Total consump-
tion of each dietary factor was then summed across
foods and converted to a daily consumption rate. For
vitamins and minerals, we evaluated consumption solely
from foods (“without supplements”) and consumption
including dietary supplements (“with supplements”). All
factors examined are listed in Additional File 1.
Finally, participants provided toenail clippings and
a sample of household tap water for analysis of total
arsenic concentration using previously established proto-
cols [45,46]. Overall, over 90% of participants provided
a toenail clipping sample. The majority of subjects (70%)
provided toenail clippings within 14 days of filling out
the FFQ; 91.5% provided clippings within one year of
the FFQ. Further, the vast majority (93.5%) of toenail
clippings were analyzed within 1 year of sample collec-
tion. Toenail clippings were analyzed at the University
of Missouri Research Reactor Center using standard-
comparator instrumental neutron activation analysis
[47]. Nail samples were carefully washed prior to ana-
lysis to remove external contamination. Drinking water
samples were analyzed at the Dartmouth Trace Element
Analysis Core following the procedures described in
Karagas et al. [45]. Specific quality control measures
were taken to ensure the accuracy of laboratory results
for both water and toenail samples [45].Statistical analyses
Prior to statistical analysis, we normalized data on toe-
nail arsenic concentrations using a natural log trans-
formation. We then excluded subjects who did not meet
the caloric thresholds suggested by Willett [48]: 18 men
below 800 calories and 13 above 4000 calories, and three
women below 500 calories and four above 3500 calories.
We also excluded one individual with an extremely high
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420% higher than the next highest concentration.
We evaluated the relation between ln-transformed toe-
nail arsenic and each dietary factor using general linear
models (SAS version 9.2), focusing on those factors that
had a statistically significant (α= 0.05) regression coeffi-
cient. For such factors, we confirmed that results were
robust to outliers. We explored associations both for the
whole population and stratified by arsenic concentration
in the subjects’ household water supply (<1 μg/L versus
≥1 μg/L), since 1 μg/L is the concentration above which
associations between toenail arsenic and drinking water
arsenic concentrations typically emerge [39].
All analyses were conducted both with and without ad-
justment for potential confounding factors. We retained
confounders that were deemed important from previous
literature [45,49,50], biological plausibility, and univariate
associations.We adjusted for five categorical variables (sex,
smoking status [never/ever], season of toenail collection
[winter, spring, summer, fall], case–control status [control,
bladder cancer, basal cell carcinoma, squamous cell carcin-
oma], and body mass index (BMI) [normal (<25 kg/m2),
overweight (between 25 kg/m2 and 30 kg/m2), obese
(≥30 kg/m2), missing]) [51] and four continuous variables
(age [years], daily intake of water from the household
water source [L/d], total energy intake [kcal/d], and water
arsenic concentrations for individuals with water arsenic
concentrations ≥1 μg/L). Because seafood is a major
source of organic arsenic [14], we also evaluated whether
including total seafood consumption in our adjustment
model affected our principal findings.
To account for multiple testing across many individual
dietary factors, we used the false discovery rate (FDR) pro-
cedures implemented in the R package Q-value [52]. Spe-
cifically, we calculated the Q-value, the minimum FDR at
which a test may be called statistically significant [53],
from the combined list of P-values generated by our two
major analyses (100 dietary factors each with a crude and
adjusted model). Q-values≤ 0.05 were considered statisti-
cally significant after correction for multiple testing.
Finally, to help interpret our regression coefficients, we
determined the percent change in predicted, back-
transformed toenail arsenic concentrations between first
quartile and third quartile consumers for each dietary fac-
tor. We made predictions using our fully adjusted general
linear models, focusing on non-smoking, control subjects
with normal BMI whose toenails were collected during
the most common season (fall) and whose water arsenic
level was< 1 μg/L, which was the group containing the
majority of participants. Using these categorical predic-
tors, we then made separate predictions for males and
females using the mean age, caloric consumption, and
water consumption; median arsenic water concentration;
and first and third quartile for the dietary factor. By usingtwo separate predictions, we could confirm that patterns
of change were generally robust to sex.
Results and discussion
Our study population included 920 individuals with
household water arsenic concentrations ranging from
0.004 μg/L to 158 μg/L (median 0.303), with a median
toenail arsenic concentration of 0.085 μg/g (IQR, 0.059 –
0.132; range 0.016 – 1.816). Household water arsenic
concentrations were generally quite low: 77% of the
population had household water <1 μg/L and 94% had
water <10 μg/L. For the 213 individuals exposed to
≥1 μg/L of arsenic in water, the median water arsenic
concentration was still relatively low, 4.154 μg/L (IQR,
2.253 – 10.160; range 1.019 – 158.050). Additional char-
acteristics of the study population are summarized in
Table 1. Summary statistics for those dietary factors
found to be significantly related to toenail arsenic are
provided in Additional File 2.
In preliminary analyses stratified by drinking water ex-
posure (<1 μg/L vs. ≥1 μg/L), we did not find meaning-
ful differences in the observed associations between
toenail arsenic concentration and dietary factors. Associ-
ation strength and direction were consistent between
strata, but our ability to detect statistically significant
associations increased with sample size, such that only
the strongest associations were detected in the higher-
exposure group (≥1 μg/L). As such, we report pooled
analyses for the entire population below.
Few factors associated with one-carbon metabolism were
identified as significant predictors of toenail arsenic
Based on studies of urinary arsenic metabolites, we
hypothesized that there would be negative relationships
between toenail arsenic concentration and dietary factors
known to be important for one-carbon metabolism (e.g.,
folic acid, protein, methionine, vitamin B12). However,
we found that only animal protein and vitamin B12 with-
out supplement had statistically significant, negative re-
gression coefficients, and estimates of effects on toenail
arsenic concentrations from Q1 to Q3 consumers were
relatively small (<7%) (Table 2A). In addition, methio-
nine was marginally significantly associated with toenail
arsenic after adjustment for potential covariates (slope
(CI) = -0.086 (-0.18, 0.0063); P= 0.068). These findings
were robust to the inclusion of total seafood consump-
tion in the adjustment model (Additional File 3).
One reason we may not have seen strong associations
between toenail arsenic concentrations and the dietary
factors involved in one-carbon metabolism is that our
population had adequate intakes of these dietary factors.
Nearly all subjects were at or above the Dietary Refer-
ence Intake (DRI) [54] for vitamin B12 (97.1%) and the
majority was at or above the DRIs for total protein
Table 1 Population characteristics, including information about the variables included in the adjustment




[As]< 1 μg/L (n = 707)
Population with water [As]
between 1 and 10 μg/L (n = 157)
Population with water
[As]> 10 μg/L (n = 56)
A. Continuous variables Mean±1SD Mean±1SD Mean±1SD Mean±1SD
Toenail arsenic (μg/g) 0.122 ± 0.136 0.102± 0.096 0.149 ± 0.154 0.292 ± 0.297
Water arsenic (μg/L) 2.711 ± 9.978 0.269± 0.225 3.806 ± 2.498 30.467 ± 27.942
Age (years) 61.0 ± 10.0 61.1 ± 10.1 60.5 ± 9.9 61.7 ± 10.1
Water consumption
from household supply (L/d)
1.11 ± 0.77 1.11 ± 0.76 1.07 ± 0.75 1.17 ± 0.94
Energy intake (kcal/d) 1919.1 ± 630.1 1907.3 ± 633.8 1934.8 ± 600.9 2024.6 ± 662.1
B. Categorical variables n % n % n % n %
Sex
Female 364 39.6 280 39.6 66 42.0 18 32.1
Male 556 60.4 427 60.4 91 58.0 38 67.9
Smoking status
Never smoked 298 32.4 224 31.7 57 36.3 17 30.4
Has smoked 622 67.6 483 68.3 100 63.7 39 69.6
Season in which the toenail sample was collected
Winter 186 20.2 142 20.1 30 19.1 14 25.0
Spring 182 19.8 144 20.4 32 20.4 6 10.7
Summer 268 29.1 191 27.0 52 33.1 25 44.6
Fall 284 30.9 230 32.5 43 27.4 11 19.6
Case–control Status
Control 227 24.7 179 25.3 33 21.0 15 26.8
Bladder cancer 275 29.9 206 29.1 45 28.7 24 42.9
Basal cell skin cancer 214 23.3 162 22.9 40 25.5 12 21.4
Squamous cell skin cancer 204 22.2 160 22.6 39 24.8 5 8.9
Body mass index
Normal (<25 kg/m²) 164 17.8 119 16.8 37 23.8 8 14.3
Overweight
(≥25 kg/m² & <30 kg/m²)
176 19.1 142 20.1 28 17.8 6 10.7
Obese (≥30 kg/m²) 73 7.9 56 7.9 14 8.9 3 5.4
Missing 507 55.1 390 55.2 78 49.7 39 69.6
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after folic acid fortification of enriched grain products in
the USA (phased in from 1996-1998 [55]), which likely
helped contribute to adequate folate intake.
Alternatively, the factors affecting toenail arsenic con-
centrations, a long-term biomarker of arsenic exposure,
may differ from the factors affecting short-term detoxifi-
cation and excretion, as indicated by urinary arsenic
concentrations. A study comparing long and short term
biomarkers in both well-nourished and poorly nourished
populations, with drinking water exposures ranging from
very low (<1 μg/L) to >10 μg/L (the current USEPA
drinking water standard) would help to identify which
dietary factors have the greatest effect on toenail arsenic
concentration.Many dietary lipids were inversely associated with
toenail arsenic
Of the 20 dietary factors inversely associated with ln-
transformed toenail arsenic, 16 were dietary lipids
(Table 2A) and these findings were robust to the inclu-
sion of total seafood consumption in our adjustment
model (Additional File 3). Ten of these factors remained
significant after correction for multiple testing: total fat
(Figure 1A), total monounsaturated fat, total polyunsat-
urated fat, total saturated fat, and several individual fatty
acids (Table 2A). The magnitudes of effect varied, ran-
ging from relatively small (4-8%) for several of the fatty
acids to quite large (15-20%) for total fat (Table 2A).
It is not clear why so many dietary lipids were nega-
tively associated with toenail arsenic in this study
Table 2 Dietary factors that were significantly associated with toenail arsenic concentration (bold)a: Q-values ≤ 0.05
are noted with a * next to the P value
Variable Regression slopes
Crude (n = 920) Adjusteda (n = 914)








Total fat (g) -1.5E-03 (-3.0E-03, 3.5E-05) 0.056 -5.8E-03 (-8.4E-03, -3.2E-03) <0.001* -20.6 -16.4
Animal fat (g) -1.8E-03 (-4.2E-03, 5.7E-04) 0.14 -4.2E-03 (-7.2E-03, -1.2E-03) 0.006 -9.3 -7.1
Vegetable fat (g) -2.4E-03 (-5.1E-03, 3.0E-04) 0.081 -4.9E-03 (-8.5E-03, -1.3E-03) 0.008 -10.6 -8.7
Total unsaturated fat
Total monounsaturated fat (g) -3.6E-03 (-7.4E-03, 1.0E-04) 0.057 -1.2E-02 (-1.8E-02, -5.6E-03) <0.001* -17.0 -14.1
Palmitoleic fatty acid (g) -4.4E-02 (-1.1E-01, 2.1E-02) 0.18 -1.0E-01 (-1.8E-01, -1.9E-02) 0.016 -8.1 -6.8
Oleic fatty acid (g) -4.2E-03 (-8.3E-03, -7.6E-05) 0.046 -1.3E-02 (-2.0E-02, -6.4E-03) <0.001* -17.1 -13.5
Total polyunsaturated fat (g) -5.5E-03 (-1.3E-02, 2.1E-03) 0.16 -1.8E-02 (-2.9E-02, -7.3E-03) 0.001* -13.2 -10.2
Total n-6 fatty acidsd (g) -6.1E-03 (-1.4E-02, 2.2E-03) 0.15 -1.8E-02 (-2.9E-02, -6.5E-03) 0.002* -11.7 -9.7
Linoleic fatty acid (g) -7.1E-03 (-1.6E-02, 1.6E-03) 0.11 -2.0E-02 (-3.2E-02, -8.7E-03) <0.001* -13.0 -10.2
Linolenic fatty acid (g) -3.8E-02 (-1.2E-01, 4.1E-02) 0.35 -1.6E-01 (-2.7E-01, -5.4E-02) 0.003* -10.8 -9.3
Arachadonic fatty acid (g) -4.3E-01 (-1.1E + 00, 2.1E-01) 0.19 -6.8E-01 (-1.3E + 00, -4.0E-02) 0.037 -5.3 -4.7
Total saturated fat (g) -3.5E-03 (-7.5E-03, 4.8E-04) 0.084 -1.0E-02 (-1.6E-02, -4.5E-03) <0.001* -13.4 -10.8
Lauric fatty acid (g) -1.2E-01 (-2.3E-01, -4.5E-04) 0.049 -1.7E-01 (-2.9E-01, -4.8E-02) 0.006 -6.5 -5.1
Palmitic fatty acid (g) -6.7E-03 (-1.4E-02, 8.2E-04) 0.081 -2.2E-02 (-3.4E-02, -1.1E-02) <0.001* -15.5 -12.8
Stearic fatty acid (g) -1.8E-02 (-3.3E-02, -3.0E-03) 0.018 -4.3E-02 (-6.5E-02, -2.1E-02 <0.001* -15.6 -12.8
Steroid
Cholesterol (mg) -2.9E-04 (-6.3E-04, 3.9E-05) 0.084 -5.0E-04 (-8.7E-04, -1.4E-04) 0.007 -7.3 -6.2
Protein
Animal protein (g) -7.3E-04 (-2.7E-03, 1.3E-03) 0.47 -2.6E-03 (-5.0E-03, -1.5E-04) 0.037 -6.6 -6.4
Vitamins
Retinole (IU) -3.2E-05 (-5.7E-05, -7.3E-06) 0.011 -2.9E-05 (-5.2E-05, -6.1E-06) 0.013 -3.8 -3.2
Vitamin B12e (μg) -8.5E-03 (-1.6E-02, -1.1E-03) 0.024 -7.6E-03 (-1.5E-02, -5.2E-04) 0.035 -3.1 -2.3
Plant-compounds







0.035 1.4E-01 (4.6E-04, 2.8E-01) 0.049 3.5 3.4
n-3 Fatty acidsi
(EPA & DHA) (g)
1.8E-01 (1.3E-02, 3.4E-01) 0.034 1.5E-01 (1.6E-03, 3.0E-01) 0.048 3.4 3.6
EPA (g) 4.7E-01 (9.2E-02, 8.4E-01) 0.015 4.0E-01 (5.9E-02, 7.4E-01) 0.022 3.7 3.7
DPA (g) 2.9E +00 (4.4E-01, 5.3E + 00) 0.021 2.2E + 00 (-6.7E-02, 4.4E + 00) 0.057 4.5 4.5
Elements
Manganesee (mg) 3.9E-03 (6.8E-05, 7.7E-03) 0.046 5.1E-03 (-2.0E-03, 1.2E-02) 0.16 9.9 9.6
Alcohols
Ethanol (g) 6.0E-03 (3.1E-03, 8.8E-03) <0.001* 6.6E-03 (4.0E-03, 9.2E-03) <0.001* 10.0 3.2
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a Covariates included: sex, smoking status, season of toenail collection, case–control status, body mass index, age, daily intake of water from the household water
source, total energy intake, and water arsenic concentrations for individuals with water arsenic concentrations ≥1 μg/L.
b predictions made using: male, never-smoker, control, median water arsenic concentration for those <1 μg/L, normal BMI, fall toenail collection, and mean age,
calories, and water consumption for males with water arsenic < 1 μg/L.
c predictions made using: female, never-smoker, control, median water arsenic concentration for those <1 μg/L, normal BMI, fall toenail collection, and mean age,
calories, and water consumption for females with water arsenic < 1 μg/L.
d without Gamma-Linolenic Fatty Acid.
e without supplements.
f Eicosapentaenoic Fatty Acid.
g Docosapentaenoic Fatty Acid.
h Docosahexanenoic Fatty Acid.
i without Alpha-Linolenic Fatty Acid.
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published on how dietary lipids affect arsenic metabol-
ism; this past research shows either no effect or a detri-
mental effect of fats on the ability to methylate and
excrete arsenic from the body (which presumably would
result in a positive association with toenail arsenic con-
centrations). No mention is made of dietary lipids in
many previous studies in humans [18,22-25], perhaps
because they focused on poorly nourished populations
in Bangladesh. Similarly, Steinmaus et al. [26] reported
that fat, saturated fat, oleic fatty acid, linoleic fatty acid,
and cholesterol consumption were unrelated to the pro-
portions of urinary arsenic metabolites in a population
in the western United States. In contrast, Basu et al. [56]
found that animal fat intake was the strongest predictor
of the percent MMA in urinary arsenic in a population
in West Bengal, India. They hypothesize this finding is
likely due to a reduction in the second step of methyla-
tion (MMA to DMA) rather than an increase in the first
methylation step (iAs to MMA) [56]. Thus, our finding






















Figure 1 Association of toenail arsenic concentration with total fat an
transformed toenail arsenic concentration (mean plus the residuals from th
total fat consumption (g/d) and (B) positively with ethanol consumption (g
between the predictor and response variable, and so differs slightly from thFrom a physiological perspective it is conceivable
that fat could form a complex with arsenic during
digestion, inhibiting its absorption into the blood-
stream and thus resulting in both decreased exposure
and decreased toenail arsenic concentration. For ex-
ample, lipid particles associated with proteins can
interact with arsenic [57], which could provide an al-
ternative mechanism for detoxification. Another pos-
sibility is that certain dietary lipids may have higher
affinities for arsenic-containing compounds, prevent-
ing them from concentrating in toenails. Another
plausible explanation is that foods with higher fat
content contribute relatively less dietary arsenic com-
pared to carbohydrate- and protein-rich foods (such
as rice and fish) resulting in negative correlations in
our energy adjusted analysis.
Further investigation is needed to determine whether
there are biological mechanisms to account for why
short-term and long-term biomarkers appear to produce
different results regarding the effect of fats on arsenic












d alcohol in our case–control study population. The adjusted, ln-
e adjustment model described in the text) varies inversely with (A)
/d). The blue line in each panel represents the least squares regression
e lines fit in the full general linear model.
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Fatty acids typically found in fish oils were positively
associated with toenail arsenic concentration
In contrast to the relationships with other dietary lipids,
we found that intake of long chain n-3 polyunsaturated
fatty acids, both individually and combined, were posi-
tively associated with toenail arsenic concentrations
(Table 2B). Although magnitudes of effect were small
(resulting in a 3-5% change in predicted toenail arsenic
concentrations) and none of these variables was signifi-
cantly associated with toenail arsenic after correction for
multiple testing, we find these associations noteworthy.
Eicosapentaenoic fatty acid (EPA) and docosahexaenoic
fatty acid (DHA) are found in large quantities in fish oils
[58,59] and docosapentaenoic fatty acid (DPA) is a bio-
chemical intermediary between these forms [60]. Fish
have some of the highest total arsenic concentrations in
food [61,62]. This arsenic is expected to be predomin-
antly in non-toxic organic forms such as arsenobetaine,
which is not metabolized [50] and is excreted from the
body relatively quickly [14]. However, fish also contain
arsenolipids [63-66]; for example, cod-liver oil contains
six arsenolipids immediately alongside long chain n-3
fatty acids [65]. Arsenolipids can be metabolized [64],
which may release arsenic that can circulate and accu-
mulate in toenails. We speculate that the positive asso-
ciations between toenail arsenic concentrations and long
chain n-3 fatty acids may be markers for a true under-
lying relationship between arsenolipids and toenail ar-
senic, a hypothesis supported by the fact that these
associations were not detected when total seafood con-
sumption was included in our adjustment model (Add-
itional File 3). However, further studies are needed to
confirm this relationship.
Alcohol was positively associated with toenail arsenic
Consistent with previous epidemiological [32,67] and
modeling [13] studies, we found strong positive associa-
tions between toenail arsenic concentrations and con-
sumption of ethanol (Figure 1B, Table 2B), which
remained significant after correction for multiple testing
and after adjustment for total seafood consumption. This
finding is also consistent with previous research on other
biomarkers of arsenic exposure [68]. Among individuals
exposed to varying concentrations of arsenic in drinking
water, consumers of one or more alcoholic beverages per
week had significantly higher proportions of inorganic
urinary arsenic species when compared to individuals
who consumed no alcoholic beverages [68]. This finding
could be explained by alcohol’s ability to inhibit methio-
nine synthase, which is important for arsenic meta-
bolism [69]. Impeded metabolism of arsenic could alsoexplain why toenail arsenic concentration was positively
associated with alcohol consumption. In addition, alco-
holic beverages such as beer and wine may themselves
be a source of arsenic exposure [70], due to contamin-
ation of key ingredients.
Miscellaneous dietary factors were associated with
toenail arsenic
There were three dietary factors that had significant re-
gression coefficients that did not remain significant after
correction for multiple testing: retinol without supple-
ments (negatively associated), beta cryptoxanthin (nega-
tively associated), and manganese without supplements
(positively associated). These relationships were likely a
result of testing 100 dietary factors, since we know of no
scientific reason that these dietary factors would be
related to toenail arsenic.
Potential limitations
Although toenails have limitations as biomarkers [29],
these limitations likely did not affect our results. Orloff
et al. (2009) identified three major problems with nails:
(1) variability in growth rate, and thus the time period
indicated by arsenic concentrations in nail clippings, (2)
external contamination, and (3) inconsistent protocols
for collection and analysis. Because our dietary informa-
tion is averaged across a year, and our toenail clippings
represent ca. 12 months of growth [71], we believe that
the time scales for the predictor and response variables
are matched appropriately. Contamination was mini-
mized by having toenails collected immediately after
bathing and scraping, and by sonicating nails in the la-
boratory prior to analysis [72]. Finally, all nails were ana-
lyzed in the same way, creating internal consistency
within the study, even if we cannot make direct compar-
isons of toenail arsenic concentrations to other pub-
lished studies [29].
Of greater relevance to the generality of our conclu-
sions are the imprecision with which dietary factors were
assessed and the inclusion of cancer patients among the
study participants. First, our estimates of dietary factor
consumption are likely to be less precise than our esti-
mates of toenail arsenic concentration, violating one of
the assumptions of general linear models. For example,
recall bias could have affected the responses to the FFQ,
potentially underestimating consumption of ‘unhealthy’
diet items (e.g., fatty foods) and overestimating con-
sumption of ‘healthy’ items [73]. In addition, both the
rate of intake of food items and the levels of dietary fac-
tors in foods can vary greatly over a one-year period,
making it difficult to precisely estimate consumption of
specific dietary factors. However, these errors would
tend to bias results in favor of not detecting significant
relationships, due to the so-called “errors in variables”
Gruber et al. Nutrition Journal 2012, 11:45 Page 8 of 10
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tus, many of the participants were cancer cases, which
could affect the generalizability of our finding since it is
plausible that these individuals process arsenic differ-
ently than non-cancer cases.
Conclusion
This study tested the hypothesis that the dietary factors
associated with toenail arsenic concentrations in well-
nourished populations exposed to relatively low levels of
water arsenic would be similar to the dietary factors
associated with urinary arsenic concentrations in mal-
nourished, highly exposed populations. Our findings do
not support this hypothesis. Instead, several dietary
lipids were inversely related to toenail arsenic concentra-
tion in our population, possibly because they inhibit the
absorption of arsenic or its accumulation in toenails.
However, long chain n-3 fatty acids (EPA, DPA, and
DHA) were positively associated with toenail arsenic,
potentially due to the association between these long-
chain n-3 fatty acids and arsenolipids in fish tissue.
Thus, our data suggest an association between dietary
lipids and arsenic concentrations in biologic tissue.Additional files
Additional file 1: List of all dietary factors analyzed. This table
provides a list of all the dietary factors that were analyzed in this analysis.
Additional file 2: Quartiles of consumption of significant dietary
factors. This table provides summary statistics on the consumption of
significant dietary factors.
Additional file 3: Dietary factors significantly associated (bold) with
toenail arsenic with and without adjustment for seafood
consumption. This table provides a comparison of our presented results
with results that also included adjustment for total seafood consumption.
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